Revelation Biosciences, Inc. (“Revelation”), a clinical-stage life sciences company focused on the development of immunologic‑based therapies for the prevention and treatment of disease, and Petra Acquisition, Inc. (“Petra”) (NASDAQ: PAICU, PAIC, & PAICW), a special purpose acquisition company (“SPAC”), announced Monday they have entered into a definitive merger agreement for a business combination that will result in Revelation becoming a publicly traded company.
Read the full article: Revelation Biosciences, Inc. to Become Publicly Traded through a Merger with Petra Acquisition, Inc. //
Source: https://www.businesswire.com/news/home/20210830005223/en/Revelation-Biosciences-Inc.-a-Life-Sciences-Company-Developing-Therapeutics-and-Diagnostics-for-Respiratory-Viral-Infections-Including-COVID-19-to-Become-Publicly-Traded-Through-a-Merger-with-Petra-Acquisition-Inc